FUCA1 α-L - 岩藻糖苷酶 1蛋白 定量免疫 PCR 检测试剂盒
| 产品描述: | FUCA1(α-L - 岩藻糖苷酶 1)作为溶酶体糖苷水解酶家族关键成员,主要参与糖蛋白、糖脂的岩藻糖基降解代谢,其表达异常与溶酶体贮积症、肿瘤代谢重编程等病理过程密切相关,是探究溶酶体功能调控及肿瘤发生机制的重要科研靶标。本试剂盒依托定量免疫 PCR 技术,融合免疫反应特异性与 PCR 扩增高灵敏度,采用双抗夹心模式:首先让样本中的 FUCA1 与固相载体上的特异性抗体结合,再与携带特定 DNA 标记的检测抗体形成夹心复合物;随后通过 PCR 扩增与抗体相连的 DNA 片段,根据扩增产物量精确换算出 FUCA1 含量,实现对目标蛋白的精准定量。该试剂盒线性检测区间为 31.25pg/ml-1000pg/ml,可覆盖科研样本中 FUCA1 的常见表达范围,助力溶酶体贮积症相关的酶活性调控研究、肝癌等肿瘤模型中代谢通路解析;优势方面,仅需 1-2μl 微量样本即可完成检测,适配血清、血浆、组织匀浆等珍贵科研样本,且依托常规定量 PCR 仪器即可操作设备需求简洁,为溶酶体生物学及肿瘤代谢领域的基础研究提供可靠量化数据支持。 |
| 本品仅用于科研,不用于临床诊断,产品具体参数及操作步骤详见产品说明书。 |
| 别名: | α-L - 岩藻糖苷酶 1 Fucosidase Alpha L 1 |
| 缩写: | GFAP |
| UniprotNo: | P04062 |
| 种属: | Human |
| 样本类型: | serum, plasma, tissue homogenates, cell culture supernates,Cerebrospinal Fluid |
| 检测范围: | 15.62-1000pg/mL |
| 反应时间: | 1-5h |
| 样本体积: | 1-10ul |
| 检测波长: | 450 nm |
| 测定原理: | quantitative |
| 测定方法: | Amplification |
| 货期: | 3-5 working days |
| 本试剂盒所含 材料: | 固相包被板(Solid-phase Coated Plate) |
| FUCA1检测抗体(DNA 标记)(GFAP Detection Antibody (DNA-labeled)) | |
| PCR 预混液(含 Taq 酶、dNTP、缓冲液)(PCR Premix (containing Taq enzyme, dNTPs, buffer)) | |
| FUCA1 标准品(FUCA1 Standard) | |
| 阴性对照品(Negative Control) | |
| 洗涤缓冲液(Wash Buffer) | |
| DNA 扩增引物(DNA Amplification Primers) | |
| 荧光探针(Fluorescent Probe) | |
| 样本稀释液(Sample Diluent) | |
| PCR 反应管(PCR Reaction Tubes) | |
| 说明书(Instruction Manual) | |
| 精密度: | ntra-assay Precision (Precision within an assay): CV%<8% |
| Three samples of known concentration were tested twenty times on one plate to assess. | |
| Inter-assay Precision (Precision between assays): CV%<10% | |
| Three samples of known concentration were tested in twenty assays to assess. |
| 线性度: | To assess the linearity of the assay, samples were spiked with high concentrations of human ACEⅠ in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamicrange of the assay. | ||
| Sample | Serum(n=4) | ||
| 1:200 | Average % | 97 | |
| Range % | 92-105 | ||
| 1:400 | Average % | 95 | |
| Range % | 88-94 | ||
| 1:800 | Average % | 102 | |
| Range % | 92-101 | ||
| 1:1600 | Average % | 88 | |
| Range % | 82-103 | ||
| 回收率: | The recovery of human ACEⅠ spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section. | ||
| Sample Type | Average % Recovery | Range | |
| Serum (n=5) | 92 | 90-98 | |
| EDTA plasma (n=4) | 101 | 104-107 | |
| 标准曲线: | 这些标准曲线仅用于演示。应为每组分析的样品生成标准曲线。 | ||
![]() | |||
![]() | |||
| 靶点详情: | FUCA1 蛋白(Uniprot 编号:P04062)是溶酶体糖苷水解酶家族关键成员,标准中文名为 α-L - 岩藻糖苷酶 1,别名包括溶酶体 α-L - 岩藻糖苷酶、α- 岩藻糖苷酶 1 型等,其编码基因定位于人类染色体 1p36.11 区域,该基因区域的缺失或突变易导致蛋白功能异常。FUCA1 主要定位于溶酶体内,核心功能是催化糖蛋白、糖脂等生物大分子中 α-L - 岩藻糖残基的水解脱落,参与细胞糖代谢稳态维持;当 FUCA1 功能缺陷时,会引发岩藻糖苷贮积症,导致未降解的糖复合物在溶酶体蓄积,进而损伤细胞功能。此外,FUCA1 在肝癌等肿瘤组织中常出现表达上调,其表达水平与肿瘤细胞代谢重编程密切相关,是当前溶酶体生物学研究、遗传代谢病机制探究及肿瘤相关科研的重要靶标蛋白。 |
上一篇:DCP定量免疫PCR检测试剂盒
下一篇:这已经是最后一篇了